COc1ccc(C(=O)OCC2OC(n3cnc4c(=S)nc[nH]c43)C(OC(=O)c3ccc(OC)cc3)C2OC(=O)c2ccc(OC)cc2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?